TMO Stock: Unusual Options Flow Targets Both Near-Term and Long-Dated Strikes as Shares Slide

By TrendSpider Editor

Thermo Fisher Scientific Inc is drawing attention in the options market today, with four unusual contracts flagged across calls and puts totaling $1,276,485.60 in combined premium. TMO shares are trading at $464.71, down 2.22% on the session, and sit closer to the lower end of their 52-week range of

TMO Stock: Unusual Options Flow Targets Both Near-Term and Long-Dated Strikes as Shares Slide

Thermo Fisher Scientific Inc is drawing attention in the options market today, with four unusual contracts flagged across calls and puts totaling $1,276,485.60 in combined premium. TMO shares are trading at $464.71, down 2.22% on the session, and sit closer to the lower end of their 52-week range of $385.46 to $643.99. The divergence between bullish call positioning and a notable put contract adds complexity to the near-term directional read on the stock.

Key Drivers of the TMO Stock Move

The forward setup for TMO is mixed. The stock is pressing the lower half of its 52-week range after today's 2.22% decline, and the options flow reflects that uncertainty, with traders simultaneously betting on recovery via longer-dated calls and hedging or speculating on short-term weakness with a near-expiry put. The divergence between the one-week put and the ten-month call suggests the market may be pricing in near-term turbulence before any potential stabilization. Investors should watch whether the $455 level holds as support heading into next week, particularly given the open interest concentration at that strike.

TMO Unusual Options Activity

All four contracts are out of the money relative to the current price of $464.71. The total unusual premium across all contracts is $1,276,485.60. Call-side contracts dominate by count (3 of 4) and by total premium, though the put contract carries the most extreme open interest ratio of the group at 1,667%.

TMO Seasonality

Mid-March has historically represented a transitional period for large-cap life sciences and laboratory equipment names, as investors reassess positioning ahead of upcoming earnings cycles and guidance updates. With TMO trading near the lower half of its annual range, seasonal patterns often draw attention to whether current price levels represent accumulation opportunities or continued distribution.

TMO Relative Performance

TMO is down 2.22% today at $464.71, a meaningful single-session decline for a mega-cap name in the life sciences tools sector. The stock's 52-week range of $385.46 to $643.99 reflects a wide spread of roughly $258.53, and at current levels the stock is trading approximately 27.8% above its 52-week low and roughly 27.8% below its 52-week high. This positioning in the lower half of the annual range suggests TMO has meaningfully underperformed relative to where it was trading at peak levels over the past year, which provides context for why options traders may be taking asymmetric positions on both sides of the current price.